🔗 Share this article

Treasury head Reeves has stated she is planning "targeted measures to tackle cost of living pressures" in next month's financial statement.

Speaking to media outlets, she emphasized that lowering price rises is a joint responsibility of both the administration and the central bank.

The United Kingdom's inflation rate is expected to be the highest among the Group of Seven developed nations this calendar year and next.

Possible Energy Bill Interventions

It is understood the government could intervene to lower utility costs, such as by reducing the current 5% level of VAT charged on energy supplies.

Another approach is to cut some of the regulatory levies currently included in household expenses.

Fiscal Limitations and Analyst Predictions

The administration will receive the next draft from the official forecaster, the OBR, on Monday, which will reveal how much room there is for these measures.

The view from most analysts is that the Chancellor will have to declare tax increases or spending cuts in order to adhere to her declared fiscal targets.

Previously on Thursday, calculations suggested there was a £22bn deficit for the chancellor to resolve, which is at the lower end of expectations.

"There's a collective responsibility between the Bank of England and the administration to bear down further on some of the drivers of price increases," the Chancellor informed reporters in Washington, at the yearly gatherings of the International Monetary Fund and global financial institution.

Revenue Commitments and International Issues

While much of the attention has been on expected tax rises, the chancellor said the latest data from the OBR had not changed her pledge to election pledges not to increase tax levels on income tax, sales tax or National Insurance.

She blamed an "uncertain world" with increasing international and trade issues for the fiscal revenue measures, likely to be focused on those "with the broadest shoulders."

International Economic Disputes

Referring to apprehensions about the United Kingdom's trade ties with the Asian nation she said: "The UK's security interests always take priority."

Recent announcement by China to tighten export controls on critical minerals and other resources that are key for high-technology production led US President Donald Trump to suggest an additional 100% tariff on goods from China, raising the risk of an all-out trade war between the two largest economies.

The American finance chief described China's decision "economic coercion" and "a global supply chain control attempt."

Questioned on accepting the US offer to participate in its dispute with the Asian nation, the Chancellor said she was "extremely troubled" by China's measures and encouraged the Chinese government "to avoid restrictions and limit trade."

She said the decision was "bad for the world economy and causes further obstacles."

"In my view there are fields where we should challenge Chinese policies, but there are also significant opportunities to trade with Chinese markets, including financial services and other areas of the economic system. We've got to get that balance appropriate."

The chancellor also affirmed she was collaborating with G7 counterparts "regarding our own essential resources approach, so that we are more independent."

Health Service Medicine Costs and Funding

Reeves also admitted that the cost the NHS spends on pharmaceuticals could rise as a consequence of ongoing discussions with the US government and its drugs companies, in exchange for lower tariffs and funding.

A number of the biggest global drug companies have said in recent statements that they are either pausing or abandoning investments in the United Kingdom, with several attributing the insufficient payments they are receiving.

Last month, the government science advisor said the price the health service pays for medicines would have to go up to halt businesses and pharmaceutical investment departing from the United Kingdom.

Reeves stated to the BBC: "We have seen as a result of the pricing regime, that medical research, new drugs have not been provided in the United Kingdom in the way that they are in other EU nations."

"Our aim is to ensure that patients getting care from the NHS are can obtain the top essential drugs in the globe. And so we are examining all of that, and... seeking to obtain additional capital into the UK."